IP Library Granted Patent US 9,717,784
Granted Patent B2
US 9,717,784 · App. 14/541,268 · Granted Aug 1, 2017

Circovirus sequences associated with piglet weight loss disease (PWD)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,717,784
App. No.
14/541,268
Granted
Aug 1, 2017
Kind
B2
Abstract

The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccine, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.

Claims (8)

1. A method of inducing an immune response against porcine circovirus type B (PCVB), said method comprising administering one dose of a composition comprising a polypeptide encoded by a nucleic acid having at least 90% identity to SEQ ID NO:25 and a pharmaceutically or veterinarily acceptable carrier.

2. The method according to claim 1 , wherein said nucleic acid has at least 95% identity to SEQ ID NO:25.

3. The method according to claim 1 , wherein said nucleic acid has at least 98% identity to SEQ ID NO:25.

4. The method according to claim 1 , wherein said nucleic acid has 100% identity to SEQ ID NO:25.

5. A method of inducing an immune response against porcine circovirus type B (PCVB), said method comprising administering one dose of a composition comprising a polypeptide comprising an amino acid sequence having at least 90% identity to SEQ ID NO:26 and a pharmaceutically or veterinarily acceptable carrier.

6. The method according to claim 5 , wherein said amino acid has at least 95% identity to SEQ ID NO:26.

7. The method according to claim 5 , wherein said amino acid has at least 98% identity to SEQ ID NO:26.

8. The method according to claim 5 , wherein said amino acid has 100% identity to SEQ ID NO:26.

Assignments (2)
ASIGNEE CHANGE OF ADDRESS Recorded Apr 27, 2017
From: ZOETIS SERVICES LLC
To: ZOETIS SERVICES LLC
Reel/Frame 042351/0561 →
MERGER Recorded May 13, 2015
From: ZOETIS W LLC
To: ZOETIS SERVICES LLC
Reel/Frame 035651/0884 →